Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty

The American Journal of Cardiology

Volumn 60, Issue 4, 1987, Pages 267-270

  Feldman, Robert L ^a,b   MacDonald, Robert G ^a,b   Hill, James A ^a,b   Repine, Carl J ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICARDIPINE;

ADULT; AGED; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; ELECTROCARDIOGRAM; HEART; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; PRIORITY JOURNAL; THERAPY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON; COLLATERAL CIRCULATION; CORONARY CIRCULATION; CORONARY DISEASE; ELECTROCARDIOGRAPHY; HUMAN; ION CHANNELS; MIDDLE AGE; MYOCARDIUM; NICARDIPINE; OXYGEN CONSUMPTION;

EID: 0023258677     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(87)90225-6     Document Type: Article

References (26)

1. Evaluation of coronary collateral circulation in conscious humans
2. ST segment response to acute coronary occlusion: coronary hemodynamic and angiographic determinants of direction of ST segment shift
3. Effect of nitroglycerin on coronary collateral flow pressure during acute coronary occlusion
4. Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion
5. Myocardial protection during transient coronary artery occlusion in man: beneficial effects of regional B-adrenergic blockade
6. Amelioration by nitroglycerin of left ventricular ischemia induced by percutaneous iransluminal coronary angioplasty: assessment by homodynamic variables and left ventriculography
7. Dose-related effects of intracoronary nitroglycerin on coronary hyperemia in patients with coronary artery disease
8. Myocardial protection by intracoronary injection of nicardipine during transluminal coronary angioplasty (abstr)
9. Regional cardioprotection by intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty (abstr)
10. Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty
11. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%
12. Distal hemoperfusion during percutaneous transluminal coronary angioplasty
13. In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary disease
14. Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog
15. Coronary and systemic hemodynamic effects of nicardipine
16. Effects of nicardipine on left ventricular function and energetics in man
17. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease
18. Effects of diltiazem during tachycardia-induced angina pectoria
19. Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion
20. Effects of nifedipine on coronary hemodynamic findings during exercise in patients with stable exertional angina
21. Coronary haemodynamic effects of nifedipine comparison with glyceryl trinitrate
22. Mechanisms of angina relief after nifedipine: a hemodynamic and myocardial metabolic study
23. Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action
24. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyrinde-3,5-dicardobxylic acid 3-(2-(N-benzyl-N-methylamino)) ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator
25. Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty
26. Regional myocardial dysfunction during coronary angioplasty: evaluation by two-dimensional echocardiography and 12 lead electro-cardiography